Bardia A - Search Results

1

Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysis.

Spring LM, Fell G, Arfe A, Sharma C, Greenup R, Reynolds KL, Smith BL, Alexander B, Moy B, Isakoff SJ, Parmigiani G, Trippa L, Bardia A. Spring LM, et al. Among authors: bardia a. Clin Cancer Res. 2020 Jun 15;26(12):2838-2848. doi: 10.1158/1078-0432.CCR-19-3492. Epub 2020 Feb 11. Clin Cancer Res. 2020. PMID: 32046998 Free PMC article.

2

Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition.

Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT, Isakoff SJ, Ciciliano JC, Wells MN, Shah AM, Concannon KF, Donaldson MC, Sequist LV, Brachtel E, Sgroi D, Baselga J, Ramaswamy S, Toner M, Haber DA, Maheswaran S. Yu M, et al. Among authors: bardia a. Science. 2013 Feb 1;339(6119):580-4. doi: 10.1126/science.1228522. Science. 2013. PMID: 23372014 Free PMC article.

3

Neoadjuvant therapy as a platform for drug development and approval in breast cancer.

Bardia A, Baselga J. Bardia A, et al. Clin Cancer Res. 2013 Dec 1;19(23):6360-70. doi: 10.1158/1078-0432.CCR-13-0916. Clin Cancer Res. 2013. PMID: 24298066 Review.

4

Hemodynamic signature of breast cancer under fractional mammographic compression using a dynamic diffuse optical tomography system.

Carp SA, Sajjadi AY, Wanyo CM, Fang Q, Specht MC, Schapira L, Moy B, Bardia A, Boas DA, Isakoff SJ. Carp SA, et al. Among authors: bardia a. Biomed Opt Express. 2013 Nov 22;4(12):2911-24. doi: 10.1364/BOE.4.002911. eCollection 2013. Biomed Opt Express. 2013. PMID: 24409390 Free PMC article.

5

Precision medicine and personalized breast cancer: combination pertuzumab therapy.

Reynolds K, Sarangi S, Bardia A, Dizon DS. Reynolds K, et al. Among authors: bardia a. Pharmgenomics Pers Med. 2014 Mar 20;7:95-105. doi: 10.2147/PGPM.S37100. eCollection 2014. Pharmgenomics Pers Med. 2014. PMID: 24715764 Free PMC article. Review.

6

Solidifying liquid biopsies: can circulating tumor cell monitoring guide treatment selection in breast cancer?

Bardia A, Haber DA. Bardia A, et al. J Clin Oncol. 2014 Nov 1;32(31):3470-1. doi: 10.1200/JCO.2014.57.1505. Epub 2014 Jul 14. J Clin Oncol. 2014. PMID: 25024075 No abstract available.

7

Gene-Expression-Based Predictors for Breast Cancer.

Gupta A, Mutebi M, Bardia A. Gupta A, et al. Among authors: bardia a. Ann Surg Oncol. 2015 Oct;22(11):3418-32. doi: 10.1245/s10434-015-4703-0. Epub 2015 Jul 28. Ann Surg Oncol. 2015. PMID: 26215189 Review.

8

Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence.

Keenan T, Moy B, Mroz EA, Ross K, Niemierko A, Rocco JW, Isakoff S, Ellisen LW, Bardia A. Keenan T, et al. Among authors: bardia a. J Clin Oncol. 2015 Nov 1;33(31):3621-7. doi: 10.1200/JCO.2015.62.2126. Epub 2015 Sep 14. J Clin Oncol. 2015. PMID: 26371147 Free PMC article.

9

Targeting the cyclin D-cyclin-dependent kinase (CDK) 4/6-retinoblastoma pathway with selective CDK 4/6 inhibitors in hormone receptor-positive breast cancer: rationale, current status, and future directions.

Spring L, Bardia A, Modi S. Spring L, et al. Among authors: bardia a. Discov Med. 2016 Jan;21(113):65-74. Discov Med. 2016. PMID: 26896604 Free PMC article.

10

Neoadjuvant Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer: A Systematic Review and Meta-analysis.

Spring LM, Gupta A, Reynolds KL, Gadd MA, Ellisen LW, Isakoff SJ, Moy B, Bardia A. Spring LM, et al. Among authors: bardia a. JAMA Oncol. 2016 Nov 1;2(11):1477-1486. doi: 10.1001/jamaoncol.2016.1897. JAMA Oncol. 2016. PMID: 27367583 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

362 results

Search Page